Country for PR: United States
Contributor: PR Newswire New York
Monday, October 05 2020 - 08:35
AsiaNet
Expert Breast Cancer Treatment Recommendations Based on Latest Evidence Updating for Multiple Languages
PLYMOUTH MEETING, Pennsylvania, Oct. 5, 2020 /PRNewswire-AsiaNet/ --

--Ongoing updates are underway for NCCN Guidelines for Breast Cancer in 
Chinese, English, French, Japanese, Korean, Spanish, Polish, and Portuguese, 
free online at NCCN.org/global ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1922784669&u=http%3A%2F%2Fwww.nccn.org%2Fglobal&a=NCCN.org%2Fglobal 
). Follow #NCCNGlobal ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3670714091&u=https%3A%2F%2Ftwitter.com%2Fsearch%3Fq%3D%2523NCCNGlobal%26src%3Dtyped_query%26f%3Dlive&a=%23NCCNGlobal 
) for more.

--NCCN Foundation is hosting free metastatic breast cancer webinars for 
patients and caregivers on October 8 and 12 at NCCN.org/patients ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2281405580&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fresources%2Fbreast-cancer-2020.aspx&a=NCCN.org%2Fpatients 
).

During Breast Cancer Awareness Month this October, the National Comprehensive 
Cancer Network(R) (NCCN ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3584390045&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN 
)(R)) is sharing and updating evidence- and expert consensus-based management 
recommendations which lead to optimal outcomes for people with breast cancer.1 
Translations of the English-language NCCN Guidelines ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=4286414893&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fdefault.aspx&a=NCCN+Guidelines 
)(R) for Breast Cancer ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=331602302&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23breast&a=Breast+Cancer 
) have recently been updated in Chinese, Japanese, and Spanish. The 
currently-available Korean, French, Polish, and Portuguese versions will be 
updated by the end of the month. All are free at NCCN.org/global ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3430697588&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Finternational_adaptations.aspx%23translations&a=NCCN.org%2Fglobal 
).

Photo - 
https://mma.prnewswire.com/media/1306011/NCCN_Breast_Cancer_Guidelines_Translations.jpg

Logo - https://mma.prnewswire.com/media/441768/NCCN_Logo.jpg

"Breast cancer has a very high cure rate, but remains the most common cancer 
and the leading cause of cancer-related death for women worldwide," said Robert 
W. Carlson, MD, Chief Executive Officer, NCCN and Professor of Medicine 
(Emeritus), Stanford University Medical Center, who specialized in breast 
cancer. "We want health care providers everywhere to have access to the 
carefully-vetted treatment recommendations included in the NCCN Guidelines. 
That's why we're always looking for ways to increase the readability and 
accessibility of these resources."

NCCN also adapts NCCN Guidelines into tiered and pragmatic approaches for 
varying resource availability in low- and middle-income countries, called the 
NCCN Framework for Resource Stratification of NCCN Guidelines (NCCN Framework ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=243247110&u=https%3A%2F%2Fwww.nccn.org%2Fframework%2Fdefault.aspx&a=NCCN+Framework 
)(TM)). There are also International Adaptations ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1717249067&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Finternational_adaptations.aspx&a=International+Adaptations 
) of the NCCN Guidelines for Breast Cancer for the Middle East and North Africa 
(MENA) region and Spain, as well as NCCN Harmonized Guidelines ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3863714990&u=https%3A%2F%2Fwww.nccn.org%2Fharmonized%2Fdefault.aspx&a=Harmonized+Guidelines 
)(TM) for Sub-Saharan Africa and the Caribbean, all written in collaboration 
with regional oncology experts.

The NCCN Guidelines for Breast Cancer have also served as the basis for 
creation of three volumes of NCCN Guidelines for Patients ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=593607461&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fguidelines%2Fcancers.aspx%23breast&a=NCCN+Guidelines+for+Patients 
)(R), to help cancer patients talk with their physicians about the best 
treatment options for Ductal Carcinoma in Situ (DCIS), Invasive Breast Cancer, 
and Metastatic Breast Cancer.

"We are expanding our knowledge of this disease at a rapid pace," said William 
J. Gradishar, MD, Robert H. Lurie Comprehensive Cancer Center of Northwestern 
University ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=4260489204&u=https%3A%2F%2Fwww.cancer.northwestern.edu%2F&a=Robert+H.+Lurie+Comprehensive+Cancer+Center+of+Northwestern+University 
), Chair, NCCN Guidelines Panel for Breast Cancer. "We've made six updates to 
the main breast cancer guidelines already this year. They include multiple new 
treatment recommendations covering management, staging, and special 
circumstances such as pregnancy."

NCCN also has separate guidelines on topics like screening ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2786673541&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23breast_screening&a=screening 
), genetic/familial risk assessment ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=259873968&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23genetics_screening&a=genetic%2Ffamilial+risk+assessment 
), risk reduction ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1302014153&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23breast_risk&a=risk+reduction 
), and supportive care ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1402711673&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fphysician_gls%2Fdefault.aspx%23supportive&a=supportive+care 
).

The NCCN Guidelines for Breast Cancer were downloaded more than 890,000 times 
in 2019, making it the most-downloaded NCCN guideline across all cancer types. 
At least 335,000 of those downloads came from outside the United States, 
including more than 36,000 from Spain and Mexico, 31,000 from China, and 21,000 
from Brazil. The non-English versions were downloaded more than 4,000 times.

Visit NCCN.org/global ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1922784669&u=http%3A%2F%2Fwww.nccn.org%2Fglobal&a=NCCN.org%2Fglobal 
) to learn more about all of the available cancer resources, and join the 
conversation with the hashtag #NCCNGlobal ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3670714091&u=https%3A%2F%2Ftwitter.com%2Fsearch%3Fq%3D%2523NCCNGlobal%26src%3Dtyped_query%26f%3Dlive&a=%23NCCNGlobal 
).

Free Breast Cancer Patient Webinars
The NCCN Foundation ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1527897431&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Ffoundation%2Fdefault.aspx&a=NCCN+Foundation 
)(R) is hosting two free patient webinars about metastatic breast cancer on 
October 8 ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=167798350&u=https%3A%2F%2Fnccn.webex.com%2Fnccn%2Fonstage%2Fg.php%3FMTID%3De05672800f6dc1b47eaaff34559cf0407&a=8 
) and 12 ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1290350781&u=https%3A%2F%2Fnccn.webex.com%2Fnccn%2Fonstage%2Fg.php%3FMTID%3De2dd47c432f0e7c353e5e5e3b9fa6c2d1&a=12 
), 2020, based on the NCCN Guidelines for Patients.

Visit nccn.org/patients/resources/breast-cancer-2020.aspx ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2554640993&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fresources%2Fbreast-cancer-2020.aspx&a=nccn.org%2Fpatients%2Fresources%2Fbreast-cancer-2020.aspx 
) for more information and registration.

About the National Comprehensive Cancer Network
The National Comprehensive Cancer Network(R) (NCCN ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3584390045&u=http%3A%2F%2Fwww.nccn.org%2F&a=NCCN 
)(R)) is a not-for-profit alliance of leading cancer centers ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1399039089&u=https%3A%2F%2Fwww.nccn.org%2Fmembers%2Fnetwork.aspx&a=leading+cancer+centers 
) devoted to patient care, research, and education. NCCN is dedicated to 
improving and facilitating quality, effective, efficient, and accessible cancer 
care so patients can live better lives. The NCCN Clinical Practice Guidelines 
in Oncology (NCCN Guidelines ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=4286414893&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fdefault.aspx&a=NCCN+Guidelines 
)(R)) provide transparent, evidence-based, expert consensus recommendations for 
cancer treatment, prevention, and supportive services; they are the recognized 
standard for clinical direction and policy in cancer management and the most 
thorough and frequently-updated clinical practice guidelines available in any 
area of medicine. The NCCN Guidelines for Patients ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2135832043&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fguidelines%2Fcancers.aspx&a=NCCN+Guidelines+for+Patients 
)(R) provide expert cancer treatment information to inform and empower patients 
and caregivers, through support from the NCCN Foundation ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1634497900&u=https%3A%2F%2Fwww.nccn.org%2Fpatients%2Fwaystogive%2Fdefault.aspx&a=NCCN+Foundation 
)(R). NCCN also advances continuing education ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3465003812&u=https%3A%2F%2Feducation.nccn.org%2F&a=continuing+education 
), global initiatives ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3970539329&u=https%3A%2F%2Fwww.nccn.org%2Fglobal%2Fdefault.aspx&a=global+initiatives 
), policy ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=23804482&u=https%3A%2F%2Fwww.nccn.org%2Fprofessionals%2Fmeetings%2Foncology_policy_program%2Fdefault.aspx&a=policy 
), and research collaboration ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=2077981111&u=https%3A%2F%2Fwww.nccn.org%2Fclinical_trials%2Fclinicians.aspx&a=collaboration 
) and publication ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=3126579684&u=https%3A%2F%2Fwww.nccn.org%2Fjnccn%2F&a=publication 
) in oncology. Visit https://NCCN.org for more information and follow NCCN on 
Facebook @NCCNorg ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=4064464649&u=http%3A%2F%2Fwww.facebook.com%2FNCCNorg&a=%40NCCNorg 
), Instagram @NCCNorg ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=1387959517&u=https%3A%2F%2Fwww.instagram.com%2Fnccnorg%2F&a=%40NCCNorg 
), and Twitter @NCCN ( 
https://c212.net/c/link/?t=0&l=en&o=2935259-1&h=787793643&u=http%3A%2F%2Fwww.twitter.com%2Fnccn&a=%40NCCN 
).
		
1 Vaddepally. J Clin Oncol 36, suppl 30; abstr 47, 2018, 
https://meetinglibrary.asco.org/record/166668/abstract. 

Media Contact: 
Rachel Darwin
+1 267-622-6624
darwin@nccn.org

SOURCE: National Comprehensive Cancer Network 
Translations

Vietnamese

Japanese